Development and Validation of a Multimodal Artificial Intelligence Model for Early Prediction of Acute Myocardial Infarction
1 other identifier
observational
1,500
1 country
1
Brief Summary
Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
March 9, 2026
November 1, 2025
1.5 years
March 4, 2026
March 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic performance
the diagnostic performance (AUC) for predicting the risk of acute myocardial infarction (AMI) within 6 months
6 months
Study Arms (1)
MI group
Patients who present with myocardial infarction and undergo successful percutaneous coronary intervention will be eligible for enrollment.
Interventions
Eligibility Criteria
Patients with myocardial infarction
You may qualify if:
- Age ≥18 years old
- Presented with myocardial infarction, including NSTEMI and STEMI
- Undergoing successful percutaneous coronary intervention.
You may not qualify if:
- Poor imaging quality or a data missing rate \>30%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009
Hangzhou, Zhejiang, 310000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2026
First Posted
March 9, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
March 9, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share